相关实验视频

Updated: Feb 28, 2026

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

儿童多动症中的神经保护性海洋生物活性:对治疗潜力的集中审查

Benu Chaudhary¹, Preeti Arya², Praveen Kumar³

¹Department of Pharmacy, Panipat Institute of Engineering and Technology, Panipat, Haryana, India.

CNS & neurological disorders drug targets

|February 27, 2026

概括

海洋生物活性物在治疗儿童注意力缺陷/多动障碍 (ADHD) 方面表现有前途. 这些天然化合物提供潜在的神经保护性益处,支持认知功能和神经发育,作为传统治疗的替代方案.

科学领域:

神经科学是一个神经科学.
海洋生物学海洋生物学
儿科儿科儿科

背景情况:

注意缺陷/多动障碍 (ADHD) 是儿童中普遍存在的一种神经发育疾病.
症状包括注意力不集中,过度活跃和冲动,影响认知功能和发展.
海洋衍生生物活性化合物正在探索它们在支持神经发育和管理ADHD症状方面的潜力.

研究的目的:

审查海洋衍生生物活性化合物的潜力,以管理儿童的ADHD.
分析具有治疗价值的化合物,用于ADHD管理.
突出传统ADHD治疗的自然替代方案.

主要方法:

在包括PubMed,Scopus,Web of Science和ClinicalTrials.gov.gov在内的数据库中进行系统的文献搜索.
包括人类临床试验和临床前研究到2025年7月.
专注于与海洋生物活性和儿童ADHD或神经发育结果相关的研究.

主要成果:

海洋来源含有神经保护剂,如多可萨赫萨酸 (DHA) 和埃可萨酸 (EPA),对大脑发育至关重要.
诸如Klamin® (来自Aphanizomenon flos-aquae) 等化合物显示出通过单胺氧化酶B抑制来调节注意力的潜力.
海洋和多糖具有与ADHD相关的抗炎和神经再生性质.

结论:

海洋生物活性提供了一种通过营养干预来管理ADHD的新自然途径.
这些化合物为传统药理疗法提供了潜在的更安全的替代品.
进一步的临床研究至关重要,以确认疗效,最佳剂量和长期安全性.

关键词:

神经保护是一种神经保护.这是一种抗炎药物.抗氧化剂是一种抗氧化剂.注意力缺陷障碍是一种注意力缺陷障碍.过度活动障碍过度活动障碍海洋生物活性的海洋生物.神经再生性质. 神经再生性质.

更多相关视频

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

Electroencephalographic Signal Acquisition Framework for Neurodiverse: A Case Study of Dolphin-Assisted Therapy

Electroencephalographic Signal Acquisition Framework for Neurodiverse: A Case Study of Dolphin-Assisted Therapy

Published on: June 27, 2025

相关概念视频

Attention-Deficit/Hyperactivity Disorder

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...

Drugs Affecting Neurotransmitter Release or Uptake

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...